We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

62 hedge funds and large institutions have $177M invested in Five Prime Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 12

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

11% more funds holding

Funds holding: 56 → 62 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

18% less capital invested

Capital invested by funds: $215M → $177M (-$37.7M)

Holders
62
Holders Change
+6
Holders Change %
+10.71%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
26
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
QF
QVT Financial
New York
+$4.94M
2
EAM
Eventide Asset Management
Massachusetts
+$3.73M
3
BFA
BlackRock Fund Advisors
California
+$3.31M
4
SAM
Senzar Asset Management
New York
+$3.06M
5
BI
BVF Inc
California
+$1.68M

Top Sellers

1
HM
HealthCor Management
New York
-$8.2M
2
WT
Wellcome Trust
United Kingdom
-$7.17M
3
Millennium Management
Millennium Management
New York
-$2.87M
4
ACPU
Arrowgrass Capital Partners (US)
Delaware
-$1.79M
5
SFM
Sphera Funds Management
Israel
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$828K +$112K +7,799 +17%
BIM
27
BlackRock Investment Management
Delaware
$765K +$427K +29,770 +153%
GPCM
28
Granite Point Capital Management
Massachusetts
$622K -$252K -17,600 -31%
TAM
29
Tocqueville Asset Management
New York
$591K -$28.7K -2,000 -5%
Allianz Asset Management
30
Allianz Asset Management
Germany
$550K -$52.5K -3,658 -9%
NFA
31
Nationwide Fund Advisors
Ohio
$527K +$114K +7,930 +31%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$490K +$275K +19,200 +156%
TC
33
TFS Capital
Pennsylvania
$420K +$211K +14,698 +119%
TRSOTSOK
34
Teachers Retirement System of the State of Kentucky
Kentucky
$417K – – –
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$400K +$369K +25,700 New
Charles Schwab
36
Charles Schwab
California
$394K +$363K +25,300 New
BCM
37
Bridgeway Capital Management
Texas
$373K – – –
TA
38
Teachers Advisors
New York
$373K +$134K +9,327 +64%
NI
39
Numeric Investors
Massachusetts
$372K +$343K +23,900 New
BBA
40
Baker Bros. Advisors
New York
$308K – – –
Morgan Stanley
41
Morgan Stanley
New York
$280K +$181K +12,625 +235%
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$219K +$202K +14,105 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$199K +$184K +12,820 New
VOYA Investment Management
44
VOYA Investment Management
Georgia
$198K +$182K +12,705 New
AL
45
Airain Ltd
Guernsey
$180K +$166K +11,588 New
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$176K +$132K +9,198 +441%
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$176K +$162K +11,293 New
AIG
48
American International Group
New York
$175K +$107K +7,457 +195%
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
$174K +$159K +11,120 New
Citigroup
50
Citigroup
New York
$152K -$12.5K -875 -8%
1
2
3

FPRX Hedge Fund Activity: Q2 2014 in Review

62 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2014, worth a combined $177M — down 18% from $215M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new FPRX positions and 9 closed out — a net gain of 6 holders — while 26 added to existing stakes and 12 trimmed.

The largest buyer was QVT Financial, adding an estimated $4.94M. The largest seller was HealthCor Management, exiting entirely with an estimated $8.2M sold.

  • 62 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2014, up from 56 in Q1 2014.
  • Funds reported $177M of Five Prime Therapeutics, Inc. stock for Q2 2014, down 18% quarter-over-quarter.
  • 15 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2014 and 9 closed out, a net change of +6 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q2 2014 was QVT Financial, an estimated $4.94M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2014 was HealthCor Management, an estimated $8.2M sold.

Based on aggregated 13F filings for Q2 2014.